Drawing for GLYCARE

USPTO serial 79272144

GLYCARE

Reviewed by CopyMark Law Group

Reg. 6398644Status 700Renewal
Filing date
Status date
Registration date
Jun 29, 2021
Examiner
CHARLON, BARNEY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLYCARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

George S. Pavlik

George S. Pavlik Levenfeld Pearlstein, LLC120 S. Riverside PlazaSuite 1800Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
001Human milk oligosaccharide (HMO) preparations for use in industry and as raw material and other than for medical use, namely, for use as an ingredient in the manufacture of nutraceuticals, dietetic food and substances, dietary supplements, infant formula, foodstuffs, and animal foods; human milk oligosaccharide (HMO) additives for the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for the food industry, namely, for use as an ingredient in the manufacture of infant formula, foodstuffs, animal foods, nutraceuticals, dietetic food and substances, and dietary supplements; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for scientific research use other than for medical or veterinary use; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for industrial use, namely, for use as an ingredient in the manufacture of nutraceuticals, dietetic food and substances, dietary supplements, infant formula, foodstuffs, and animal foods; human milk oligosaccharide compounds, chemical and biological derivatives of human milk oligosaccharide compounds and chemical and biological precursors of human milk oligosaccharide compounds for use in the manufacture of pharmaceuticals, nutraceuticals, infant formula, foodstuffs and animal foods; chemicals for use as a supplement in the manufacture of dietary supplements and infant formulaACTIVE—
005Dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; preparations for use as additives for food for human or animal consumption medicated, namely, vitamin preparations for use as a supplement for dietary supplements and infant formula; food supplements for dietetic use; dietary supplements for medical use; medicated supplements for foodstuffs for humans, including for infants, and for animals; mineral food supplements; colostrum dietary supplements; dietary supplements in the form of beverages; dietary supplements for infants; human milk oligosaccharide dietary supplements; human milk oligosaccharide compounds for medical purposes, namely, nutritional supplements; human milk oligosaccharide additives for use as dietary supplements to be added to pharmaceuticals, nutraceuticals and infant formula; human milk oligosaccharide additives for use as a dietary or nutritional supplement; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for medical use, namely, as nutritional supplementsACTIVE—
029Milk, cheese, butter, yoghurt and other milk products excluding ice cream, ice milk and frozen yogurt; oils and fats for food; prepared food kits consisting primarily of meat, fish, not live, poultry, game, fruits, vegetables, eggs, milk or milk products and containing human milk oligosaccharide preparations, ready for cooking and assembly as a meal; human milk oligosaccharide preparations sold as a component of prepared food kits consisting primarily of meat, fish, not live, poultry, game, fruits, vegetables, eggs, milk or milk products ready for cooking and assembly as a mealACTIVE—
030Coffee, tea, cocoa and artificial coffee; rice, pasta and noodles; tapioca and sago; flour and preparations made from cereals, namely, bread, pastries and confectionery made of sugar; chocolate; ice cream, sorbets and other edible ices; sugar, honey, treacle; yeast, baking powder; salt, seasonings, spices, preserved garden herbs; human milk oligosaccharide preparations for culinary purposes, namely, high protein dairy-based mix for making desserts, namely, biscuits, cakes, chocolates, custards, puddings, fruit jelly candy and jelly candy, pies, cobblers, pastries, ice cream, and sorbets; human milk oligosaccharide preparations for use as food, namely, high-protein dairy-based mix for making food, namely, rice, pasta, and noodle dishes, cereals, breads, pastries, confectionery chocolate, ice cream, sorbets; human milk oligosaccharide compounds and chemical and biological derivatives of human milk oligosaccharide compounds for consumption, namely, high-protein dairy-based mix for making food/desserts, namely, biscuits, cakes, chocolates, custards, puddings, fruit jelly candy and jelly candy, pies, cobblers, pastries, rice, pasta, and noodle dishes, cereals, breads, pastries, confectionery, ice cream, sorbets; human milk oligosaccharide preparations sold as a component of prepared food kits consisting primarily of rice, pasta, noodles, tapioca, cereals, bread, pastries, confectionery chocolate, ice cream, sorbets and other edible ices, ready for cooking and assembly as a mealACTIVE—
032Beers; mineral and aerated waters; fruit beverages and fruit juices; syrups for making beverages; human milk oligosaccharide preparations sold as a component of non-alcoholic beverages, namely, soft drinks and juices, namely, fruit juices and vegetable juicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 29, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Nov 15, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2023EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Mar 23, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 8, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 20, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 20, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 29, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 29, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 10, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 23, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 21, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 21, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Apr 13, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 13, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 12, 2021GPNXNOTIFICATION PROCESSED BY IB—
Mar 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 6, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 5, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 5, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 22, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 21, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 21, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 18, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 18, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 18, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 30, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 17, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 16, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 28, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 28, 2019RFRRREFUSAL PROCESSED BY MPU—
Dec 3, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 2, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 26, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 22, 2019DOCKASSIGNED TO EXAMINER—
Nov 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance